FDA Bans Candy- and Fruit-Flavored Cigarettes
The FDA announced today that, effective immediately, cigarettes with certain flavors such as candy, fruit, and clove are now illegal in the United States. Flavored cigarettes are a gateway for many young people to become regular smokers, the agency said, and the ban, authorized by the new Family Smoking Prevention and Tobacco Control Act, aims to reduce the number of children who start smoking.
Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination, Japanese researchers reported last week. In a large phase III clinical trial, women who received carboplatin every 3 weeks and a reduced dose of paclitaxel (Taxol) once a week for 3 weeks instead of carboplatin and a higher single dose of paclitaxel every 3 weeks had a 29 percent improvement in progression-free survival and a 25 percent improvement in overall survival after 3 years of follow-up. The results were published online September 18 in The Lancet. Read more > >
-
Commonly used drug targets cancer stem cells in mice and will be tested in a large clinical trial
-
Risk should be considered by women weighing this treatment, researchers say
-
Investigators are now asking whether the virus causes cancer
-
Interactions may contribute to poorer prognosis of obese patients
-
Immunization extends protection against hepatocellular carcinoma beyond childhood and into young adulthood
As the fiscal year draws to a close September 30, a number of offices around NCI become especially busy places. Members of our staff who supervise budget issues, grant funding, program management, and contract administration put in long hours, making sure every dollar is appropriately allocated. In 2009, end-of-year responsibilities are even greater, as NCI also works to distribute $1.26 billion it received under the American Recovery and Reinvestment Act (ARRA).
Read more > >
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
